Related Experiment Video
Updated: Jun 19, 2026

Prehospital Thrombolysis: A Manual from Berlin
Published on: November 26, 2013
Thrombolysis in children
1Department of Haematology, Birmingham Children's Hospital NHS Foundation Trust, Birmingham, UK. mike.williams@bch.nhs.uk
Insights
Thrombolytic therapy in children can restore vessel patency but carries risks of major hemorrhage. More controlled studies are needed to define optimal pediatric thrombolysis regimens and safety profiles.
Area of Science:
- Pediatric vascular medicine
- Hematology
- Pediatric critical care
Background:
- Pediatric thrombosis can lead to severe complications like limb loss and post-thrombotic syndrome.
- Thrombolytic therapy is increasingly used in children to prevent these complications.
- Optimal treatment protocols and safety data for pediatric thrombolysis remain limited.
Purpose of the Study:
- To review the current use of thrombolytic treatment in pediatric patients.
- To summarize outcome data and adverse events associated with pediatric thrombolysis.
- To highlight the limitations of existing studies on thrombolytic therapy in children.
Main Methods:
- Systematic review of published literature on pediatric thrombolysis.
- Analysis of outcome data including vessel patency and complications.
- Evaluation of reported adverse events, particularly hemorrhage.
Main Results:
- Thrombolysis has shown success in restoring vessel patency in children.
- Significant concerns remain regarding the risk of intracranial and other major hemorrhages.
- Lack of controlled, prospective studies hinders accurate efficacy and safety assessment.
Conclusions:
- While thrombolysis can be effective in pediatric thrombosis, careful consideration of bleeding risks is crucial.
- Further high-quality research is necessary to establish evidence-based guidelines for pediatric thrombolytic treatment.
- Addressing the limitations of current studies will improve patient outcomes and treatment safety.
Abstract:
Thrombosis in children may result in vascular occlusion and a potential loss of viability in skin, limbs or organs, or lead to the development of post thrombotic syndrome. Thrombolysis may prevent such complications, and the use of thrombolytics in children has increased in the last three decades. Despite this, optimum paediatric treatment regimens for these drugs remain uncertain, and accurate efficacy and safety profiles for thrombolytics are limited by the lack of controlled, prospective studies in well-defined patient populations. Restoration of vessel patency has often been achieved but the risk of intracranial and other major haemorrhage secondary to thrombolysis continues to be a significant concern for the clinician deciding on such treatment. This review summarises the use of thrombolytic treatment in children and describes outcome data and adverse events following treatment, as well as the limitations of published studies on paediatric thrombolysis.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Clot Retraction and Fibrinolysis
Pulmonary Embolism III: Nursing Management
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...

